dhodh modulates transcriptional elongation neural crest melanoma 
melanoma tumour transformed melanocytes originally derived embryonic neural crest unknown extent programs regulate neural crest development interact mutations braf oncogene commonly mutated gene human melanoma used zebrafish embryos identify initiating transcriptional events occur activation human brafv600e encodes amino acid substitution mutant braf neural crest lineage zebrafish embryos transgenic mitfa:brafv600e lack p53 also known tp53 gene signature enriched markers multipotent neural crest cells neural crest progenitors embryos fail terminally differentiate determine whether early transcriptional events important melanoma pathogenesis performed chemical genetic screen identify small-molecule suppressors neural crest lineage tested effects melanoma one class compound inhibitors dihydroorotate dehydrogenase dhodh example leflunomide led almost complete abrogation neural crest development zebrafish reduction self-renewal mammalian neural crest stem cells leflunomide exerts effects inhibiting transcriptional elongation genes required neural crest development melanoma growth used alone combination specific inhibitor brafv600e oncogene dhodh inhibition led marked decrease melanoma growth vitro mouse xenograft studies taken together studies highlight developmental pathways neural crest cells direct bearing melanoma formation 
